Lilly’s new eczema drug scores in late-stage studies
Once known primarily for its work in diabetes, Lilly has, for years now, been branching into other areas of drug development like immunology.
There, the company has ...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.